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Studies were performed in the rat to determine the effect oflithium on electrolyte transport
in distal portions of the nephron since steep corticomedullary gradient for lithium has been
demonstrated and ionic competition and/or substitution oflithium for sodium and potassium
may play a role in inhibition of vasopressin-induced water transport. During the intravenous
infusion of LiCl, in the absence ofvolume expansion and at plasma levels of 2-5 mequiv/liter
of Li, maximum urine concentration was inhibited. Under the same conditions lithium
administration impaired potassium secretion and urinary acidification and resulted in a
natriuresis. These results indicate that lithium affects electrolyte transport in the same
nephron segments in which the action ofvasopressin is inhibited.
In addition, evidence is provided that suggests that during the chronic administration of
LiCl, the sustained increase in oral intake of water and urinary flow rate results from an in-
crease in thirst as well as reduced renal concentrating ability.
The complex array oflithium-induced biological effects on water and electrolyte
transport has received increasing attention since introduction of lithium to treat
psychiatric disorders in man. It is now well established that lithium can produce a
reversible nephrogenic diabetes insipidus syndrome in man (1) and experimental ani-
mals (2) as well as block vasopressin-induced water transport in physiological
models in vitro (1, 3). Interest in lithium has also included its effect on renal
electrolyte transport in vivo (4, 5), on electrolyte movement in ion-substitution ex-
periments in vitro (6, 7), and recently the possible usefulness oflithium as a marker
forproximal tubular reabsorption (8).
The present experiments were designed to examine the effect of lithium on
electrolyte transport in distal portions ofthe nephron, since lithium is concentrated
in the hypertonic renal medulla (2, 9), and lithium-induced alterations in electrolyte
concentration and movement may play a role in the inhibition of the action of
vasopressin on water transport (10). Since previous studies have suggested that
lithium may also increase urinary flow rate through a central action (11), an experi-
mental model was developed so that possible changes in electrolyte transport could
be studied under conditions known to include inhibition of vasopressin on water
transport.
METHODS
Studies were performed in male Sprague-Dawley rats (Charles River Breeding
Laboratories, Wilmington, Massachusetts) with an initial weight of 125-200 g. To
evaluate the effect oflithium on renal concentrating ability- and on the reabsorption
and secretion of electrolytes, experiments were performed during chronic lithium
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treatment and in acute studies in which previously treated and untreated animals
were infused intravenously with lithium.
CHRONIC EXPERIMENTS
Experimental animals were injected intraperitoneally (IP) with LiCl (0.3 M) in a
dose of 4 mequiv/kg body weight per day, fed normal Purina Chow, and given tap
water to drink. Control rats were given 4 mequiv/kg body weight per day of NaCl
(0.3 M) IP, fed normal Purina Chow, and given a 5% glucose solution to drink in
order to produce a comparable diuresis. Fluid intake was estimated daily from the
change in weight ofthe water bottle.
In order to determine whether urinary flow rate changed or remained constant
during the 24-hr period after the single daily injection ofLiCl, six experimental ani-
mals were placed in metabolic cages on the seventh day ofchronic treatment while
food and water were provided ad lib. Urine volume was measured during the inter-
vals 0-6, 6-12, and 12-24hr following the IP injection ofLiCl.
The concentration of lithium in the plasma of rats on chronic treatment was
measured on the seventh day in six animals during the 24-hr interval after the single
daily injection of LiCl. Blood samples were obtained from the orbital plexus during
ether anesthesia.
Plasma osmolality was determined in eight experimental and eight control ani-
mals on the seventh day of chronic treatment 24 hr after the last single daily in-
jection. In addition, plasma osmolality was determined in eight normal nondiuretic
rats and in 12 animals with hereditary neurogenic diabetes insipidus (Brattleboro
strain)and on ad lib. diet ofPurina Chow and tap water.
To determine maximum urinary concentration ability in rats on chronic lithium
treatment, studies were performed in six experimental and seven control animals.
On the seventh day of treatment and 24 hr after the last single daily injection of
either LiCl or NaCl, anesthesia was induced with Inactin (100 mg/kg body weight)
(Promonta, Hamburg, Germany), and the urine was immediately aspirated from
the bladder for determination of the baseline urine osmolality. Thereafter, a
tracheostomy was performed, and polyethylene tubing (PE 50) was secured into one
jugular vein and the bladder. Aqueous vasopressin (Pitressin: Park, Davis & Co.,
Detroit, Michigan) in a concentration of 3 mU/ml of 0.15 M NaCl was infused
intravenously at a rate of 1.2 ml/hr. This dose of aqueous vasopressin (60AU/min)
has previously been shown to produce maximal urinary concentration in rats with
hereditary neurogenic diabetes insipidus (12). Urine was collected under oil for de-
termination ofosmolality during six consecutive 30-min intervals after initiating the




These experiments were performed to determine maximum urine concentration
during the acute infusion oflithium chloride in the absence ofvolume expansion and
while plasma levels of lithium were relatively constant. Animals were anesthetized
and surgically prepared as in the previous group of experiments (chronic experi-
ments). In experimental animals, following the placement ofcatheters, lithium was
administered intravenously in a primary dose of 0.5 ml of 0.3 M LiCl, and a main-
tenance infusion of 3 mU/ml of aqueous vasopressin in 0.15 M LiCl was begun at
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the rate of 1.2 ml/hr. This dose ofLiCl was calculated to result in a concentration of
lithium of 3-5 mequiv/liter in the plasma since the expected volume ofdistribution
was 40% of body weight and urinary fractional excretion of lithium was 30% (4).2
Control animals received a similar primary dose of0.3 M NaCl and maintenance in-
fusion of aqueous vasopressin in 0.15 M NaCl. Urine was collected under oil for os-
molality from both experimental and control animals during six sequential 30-min
periods, and plasma lithium concentration was determined at the termination ofthe
last collection period. Two groups ofanimals were studied. Group I included fiveex-
perimental rats on chronic LiCl treatment and five control animals receiving daily
injections of NaCl and drinking 5% glucose solution. The acute experiment was
performed on the seventh day of chronic treatment and 24 hr after the last single
daily injection.
Group II included 12 previously untreated normal animals. One-halfofthis group
were designated as experimental and were infused with LiCl, whereas the remaining
animals served as controls and wereinfused with NaCl.
Effect ofLithium onSodium andPotassium Excretion
Following induction of anesthesia, untreated normal rats were given either LiCl
(seven animals) or NaCl (five animals) in a manner employed in acute experiments
to determine maximum urinary concentration. In order to estimate glomerular
filtration rate, methoxy-inulin-H3 (New England Nuclear) was given in aprimeof 10
,uC (0.1 ml) and a sustaining dose of 10,C/hr in 0.15 M NaCl at 0.6 ml/hr. After 30
min of equilibration, three 30-min urine collection periods were performed. Tail
blood was obtained at the midpoint of each collection period to determine plasma
inulin concentration. Urine samples were examined for inulin, sodium, and po-
tassium concentration. An aortic blood sample was taken at theend ofthelast urine
collection to determine plasma lithium.
Effect ofLithium on Maximum UrinaryAcidification
Anesthesia was induced in previously untreated rats, and LiCl (six animals) and
NaCl (six animals) were administered acutely as in the previous group of experi-
ments. Thirty minutes after starting the sustaining infusion of0.15 M LiCl or NaCl,
an acute load ofNH4Cl was given in a dose of8 mM/kg by gastric lavage. Bladder
urine was collected under oil before and during a 2-hr interval following the NH4C1
load for determination of Ph. A sample of aortic blood was obtained anaerobically
at the termination ofthelast urine collection to measure blood pH.
Effect ofLithium on Renal Excretion ofPotassium
Following induction ofanesthesia in previously untreated animals, LiCl (eight ani-
mals) and NaCl (eight animals) were administered acutely as in the previous group
ofexperiments. In addition to the usual sustaining infusion of0.15 M LiCl or NaCl,
NaCl (0.15 M) was infused at 0.6 ml/hr through a second intravenous catheter while
two 30-min urine collection periods were performed to determine the control rate of
potassium excretion, expresed as yequiv min-' 100g-' body wt. Then KCI, in a con-
centration of 1 M, was substituted for NaCl in both groups ofanimals and infused at
0.6 ml/hr. During infusion of KCI, three 30-min collection periods were performed.
The interval 60-90 min after beginning KCI was taken as the period of maximum
2For comparison, the concentrations of lithium in plasma of patients receiving therapeutic doses of
lithium aregenerally 0.5-1.5 mequiv/liter (1).
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excretion, and an arterial blood sample was obtained at 90 min to determine the
plasma potassium and lithium concentration.
The determination of sodium and potassium in plasma and urine samples was
performed by flame photometry, utilizing a lithium internal standard. Lithium was
measured by atomic absorption spectrophotometry, and the concentration ofinulin
was counted by a liquid scintillation counter (New England Nuclear). The pH of
urine and blood samples was measured on a Radiometer pH meter, and osmolality
on an Advanced Instrument Osmometer. The unpaired Student's t test was utilized
in comparing results from different groups whenever applicable. Values are ex-
pressed as mean SEM.
RESULTS
Chronic administration of LiCl, achieved by a single daily intraperitoneal in-
jection, caused an increase in fluid intake, beginning on the first day of lithium
administration, in all animals treated. By the seventh day of chronic lithium
administration, water intake averaged 50 4 7 ml/100 g body wt per day as com-
pared to a mean of 16 + 1 in normal nondiuretic rats drinking tap water (p <
0.001). Although lithium was given as a bolus once per day, the urine flow rate, and
presumably the oral intake of water, remained relatively constant during the suc-
ceeding 24 hr. When Urine flow rate was determined during consecutive time
periods in six animals on the seventh day ofchronic treatment, shown in Fig. 1a, the
average urine flow rates were 50 a 7 gl/min during the first 6 hr after injection of4
mequiv/kg LiCl, 66 a 13 ul/min 6-12 hr after injection, and 55 i 5 pl/min 12-24 hr
after injection. It seems likely that urinary flow rate remained elevated throughout
the last collection period (12-24 hr) since the urine osmolality from the bladder as-
pirate at 24 hr was 482 i 148 mosm/kg H20, as compared to 1209 a 217 mosm/kg
H2O in normal rats drinking tap water. It was ofinterest that after a week oflithium
injections, the polydipsia and sustained polyuria observed in all chronically treated
animals were not associated with chronically elevated plasma levels oflithium. As
shown in Fig. lb, plasma lithium rose to a level of 3.6 + 0.9 mequiv/liter 1 hr after
the seventh daily injection and fell exponentially during the subsequent 23 hr. The
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FIG. 1. (a) Urine flow rate (Ai/min) on the seventh day of chronic lithium treatment during periods
0-6, 6-12, and 12-24 hr following injection of LiCl. Values represent the mean ± SEM. (b) Plasma
lithium concentration in rats on chronic lithium treatment during seventh day oftreatment. Values repre-
sent the mean ± SEM.
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TABLE 1
Plasma Osmolality in Normal Nondiuretic Rats and Experimental Groups with Polydipsiaa
Intake (ml/100 g body wt) Plasma osmolality (mosm/kg HOH)
Normal nondiuretic (8)b 16 282.1
±1 +
2.4
5% G/W polyuria (8) 3S 279.9
±3 +
2.0
LiCl polyuria (8) 50 280.8
±7 +
2.1
Neurogenic DI polyuria (12) 66 305.1c
±4 +
2.9
aValues represent mean ± SE.
bNumber of animals studied is shown in parentheses.
cIndicates ap < 0.001 as compared to normal nondiuretic animals.
24-hr plasma lithium values in rats treated by daily intraperitoneal injection were
similar to those reported by Schou (13) in animals on a moderate intake ofdietary
sodium andgiven 3 mequiv/kg perday oflithium.
In order to determine whether polydipsia and sustained high rates ofurine flow in
rats on chronic LiCl treatment were associated with evidence of chronic
dehydration, due to obligatory urinary losses of water, plasma osmolality was
measured in polydipsic rats on LiCl and compared to other groups of animals with
polydipsia resulting from other causes. As shown in Table 1, the plasma osmolality
in rats on chronic LiCl treatment and an oral intake of water of 50 7 ml/100 g
BW per day was 280.8 2.1 mosm/kg H2O. This value was not significantly
different statistically from the plasma osmolality found in normal nondiuretic rats
(282.1 2.4) with an intake of 16 i 1 ml/100 g body wt nor the level found in rats
with primary polydipsia, drinking a 5% glucose solution (279.9 2.0). In contrast,
the plasma osmolality in rats with hereditary neurogenic diabetes insipidus and im-
paired urinary concentration was significantly elevated to 305.1 i 2.9 mosm/kg
H20 (p < 0.001). The waterintake ofthis group was not significantly different from
theintake ofLiCl treated animals.
Despite the sustained water diuresis in rats on chronic lithium treatment, there
was no evidence ofimpaired concentrating ability 24 hr after the last daily injection.
Immediately after the induction ofanesthesia, urine was aspirated from the bladder
to determine baseline osmolality. Baseline osmolality of urine (U0) from rats on
chronic LiCl treatment, 24 hr after the last intraperitoneal injection, was 482.4 ±
148.2 mosm/kg H20, a value that was not significantly different from 606.3 ± 151.0
found in control rats given injections of NaCl and a 5% glucose solution to drink.
During the infusion of aqueous vasopressin, urine osmolality, in mosm/kg H20, in-
creased in both experimental (E) and control (C) animals to a similar extent in each
of the six 30-min collection periods (U1, 1418 169 C vs 1329 i 46 E; U2, 1578 +
182 C vs 1406 ± 58 E; U3, 1729 ± 231 C vs 1361 ± 76E; U4, 1742 i 240 C vs 1419 ±
115 E; U5, 1933 ±416 C vs 1516 ± 101 E; U6, 1912 + 356 C vs 1555 4 77 E).
The urine osmolality values for periods U0 and Ufi are shown in Fig. 2 (designated
as chronic Li, plasma Li < 0.5 mequiv/liter). Urine flow rate was also similar in
both groups and averaged 6.2 ± 0.8 Al/min control and 5.7 + 0.8 experimental
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FIG. 2. Borderline urine osmolality (U0) and urine osmolality 150-180 min (U6) after beginning in-
fusion of aqueous vasopressin (60 mU/min) are shown from three different groups ofexperiments. In the
left panel (chronic Li, plasma Li < 0.5 mequiv/liter), experimental animals (hatched bars) were given
daily injections of LiCl for 7 days and are compared to control rats (clear bars) given daily injections of
NaCI and a 5% glucose solution to drink. In the middle panel (chronic Li, plasma Li 3-5 mequiv/liter),
rats on chronic LiCl or NaCl treatment for 7 days were infused intravenously with LiCl or NaCI, respec-
tively, during the infusion of aqueous vasopressin (Group 1). In the right panel (untreated, plasma Li 3-5
mequiv/liter), untreated animals were infused with either LiCl (hatched bars) or NaCI (clear bars)during
the infusion of vasopressin (Group II). The symbol * indicates a p < 0.025 when control and experi-
mental values are compared. Values represent mean + SEM.
during period U6. The average plasma lithium concentration was 0.22 a 0.08
mequiv/liter, and fluid intake was similar in both groups during the 24-hr interval
preceding the study (42.3 ± 6.8 ml 100g body wt day-', control vs 46.7 ± 5.8 experi-
mental).
Acute Experiments
In contrast to animals studied during chronic treatment when plasma lithium
levels averaged less than 0.5 mequiv/liter, there was a blunted response to
vasopressin and reduced concentrating ability during the acuteinfusion ofLiCl. This
effect was seen in both animals on chronic lithium treatment and in previously un-
treated animals and occurred independently ofthe baseline urineosmolality. During
period U6, urine osmolality rose to a level of 1800-2000 mosm/kg H20 in Group I
and Group II control rats, whereas urine osmolality failed to increase above 1200
mosm/kg in either experimental group during the intravenous infusion of LiCl as
shown in Fig. 2. The plasma lithium concentration in experimental rats was 3.8 i
0.22 mequiv/liter in Group I and 4.6 i 0.4 in Group II.
To determine the effect of lithium on tubular transport of electrolytes, studies
were performed during the acute infusion oflithium sinceimpaired water movement
was clearly demonstrated under this experimental condition. Acutelithium adminis-
tration resulted in an increase in sodium and potassium excretion, as shown in Table
2. UNaV was 1.02 + 0.15 uequiv min-I 100 g body wt-I and Uk V was 1.37 i 0.07
,uequiv min-' 100 g body wtl in experimental rats, as compared to control values of
0.11 4± 0.03 (p < 0.001) and 0.72 4 0.12 (p < 0.001), respectively. Although the in-
fusion of lithium resulted in an increase in filtered sodium, it seems likely that so-
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TABLE 2
Effect of Sustained Infusion of Lithium on Renal Functiona
UNaV 1 UKV
Cin Cin V (gequiv minm (,equivmin1
Group (Al/min) (l/min 1 100gl) (Al/min1 100g1) 100 ) 100 g)
NaCl(5)b 1929 ± 14 1056 ± 8 1.9 ± 0.2 0.11 ± 0.03 0.72 ± 0.12
LiCl (7) 2955 ± 23C 1565 ± 13C 6.1 ± 0.8c 1.02 ± 0.15C 1.37 ± 0.07c
aValues represent mean ± SE.
bThe number of animals studied is shown in parentheses.
CDenotes p < 0.001 as compared to NaCl group.
dium reabsorption was reduced by the direct action of lithium since fractional so-
dium excretion was 0.53 + 0.08 in experimental animals and 0.10 + 0.05 in controls
(p < 0.001). Plasma lithium concentration was 4.3 + 0.4 mequiv/liter in the experi-
mental group.
The administration of lithium also resulted in impaired urinary acidification. In
these experiments, a moderately severe metabolic acidosis (blood pH: 7.23 + 0.06
experimental and 7.32 + 0.01 control) resulted from the administration of NH4Cl.
As shown in Fig. 3, urine pH was reduced from the baseline value of6.66 + 0.19 in
control rats to 5.51 + 0.05. In contrast, there was little change in urine pH during
acidosis in lithium-treated animals. The baseline urine pH of 7.39 + 0.18 was
decreased to a minimum value of 6.83 ± 0.09. The difference in urine pH between
lithium-treated and nontreated groups was highly significant in all time intervals
examined during acidosis (p < 0.001).
Since potassium secretion is a function of the distal portion of the nephron (14),
along with urinary concentration and the establishment of a minimal urine pH, it
was of interest to determine the effect of lithium on potassium secretion during
acute potassium loading. As shown in Table 3, the constant infusion of lithium
markedly reduced excretory rates of potassium during acute potassium loading.
During 60-90 min after initiating the infusion of IM KC1, plasma potassium rose to
6.6 + 0.3 mequiv/liter both in controls and in experimental animals. In response to
acute potassium loading, Uk V increased from 0.68 + 0.08 mequiv min-' 100 g body
wtl to 3.58 + 0.13 in control animals. In lithium treated rats, the rise in potassium
excretion was severely blunted. Uk V rose from 0.99 i 0.08 mequiv min-' 100 g
body wtl to 1.47 + 0.23. At the termination ofthe study, plasma lithium was 2.3 +
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FIG. 3. Urine pH before (baseline) and following administration ofNH4C1, 8mM/kg in rats during in-
fusion ofNaC1 (clear bars) and LiCl (hatched bars). Values represent the mean ± SEM.
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TABLE 3
Effect of Lithium on Maximal Potassium Excretiona
NaCi group LiCl group
UKV (,uequiv min1 100 gl) UKV (,equivminI 100 g1)
(8)c (8)
Control period 0.68 0.99
±0.08 ±0.08
Potassium loadingb 3.58 1.47d
±0.13 ±0.23
A change (Aequiv min1 100 g1) 2.89 0.48d
±0.11 ±0.25
aValues represent mean ± SE.
bThe potassium loading period was clearance period 60-90 min after beginning infusion of 1 MKCl.
cNumber of animals studied is shown in parentheses.
dIndicatesp < 0.025 as compared to NaCl group.
DISCUSSION
Lithium-induced diabetes insipidus is well established and has been shown to oc-
cur in some patients on chronic lithium therapy (1, 15) and in experimental animals
during both acute (16) and chronic administration (2, 9). Although the mechanism
of this effect is unclear, it seems likely that lithium acts directly on vasopressin-
sensitive cells to inhibit activation of adenyl cyclase (1, 3) or to block the action of
cAMP (2). In addition to the effect oflithium in inhibiting the action ofvasopressin,
it has been suggested that lithium may cause diuresis in the intact organism through
a central effect. Evidence to support this possibility is provided by the observation
that rats injected with LiCl consistently drink more water than animals given NaCl,
even when animals with a similar degree ofvolume contraction are compared (11).
The present study provides additional evidence to support a central effect of
lithium. All rats injected with LiCl developed an increase in water intake and urine
flow rate that was sustained when LiCl was administered in a bolus oncedaily. There
was no evidence, however, of dehydration in rats on chronic LiCl treatment after
plasma lithium levels had fallen to a low value. When compared to normal nondi-
uretic rats or animals with glucose-stimulated primary polydipsia, there was no
difference in plasma osmolality. In contrast, there was clear evidence ofdehydration
in rats with hereditary neurogenic diabetes insipidus with a water intake comparable
to that of LiCl-treated animals. Moreover, when maximum concentrating ability
was directly examined 24 hr after the last LiCl injection, while urine flow rate was
still elevated, there was no evidence that the action ofvasopressin was impaired. Evi-
dence was provided to show that urine flow rate was elevated at the time that con-
centrating ability was measured by the low urine osmolality of aspirated bladder
urine and the finding that flow rate was unchanged 12-24 hr after injection of LiCl,
as compared to the first 6 hr following injection. Previous studies (2) have dem-
onstrated that the action ofvasopressin is impaired when tested within thefirst 12 hr
after intraperitoneal injection in rats on chronic treatment. Taken together, these
data suggest that the increased water intake and urinary flow rate in animals on
chronic lithium treatment result from a direct effect in the central nervous system
as well as inhibition ofthe peripheral action ofvasopressin.
Although these experiments were not designed to identify the mechanism of the
central action oflithium, it seems likely that lithium stimulates thirst rather than in-
hibits the production or release of vasopressin. Previous studies (17) have shown
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that preincubation of the neurohypophysis in media containing lithium does not im-
pair the release of vasopressin. Furthermore, Myron Miller (personal communi-
cation) has found that urinary ADH excretion increases appropriately after
dehydration of rats on chronic lithium treatment and that ADH content decreases
normally in pituitary tissue in lithium-treated animals in response to the stimulus of
dehydration. Further evidence for a central stimulatory action oflithium to increase
thirst has been provided by recent studies of N. Berliner and J. N. Forrest
(unpublished). Despite the intense stimulation of thirst usually present in rats with
neurogenic diabetes insipidus, administration of LiCl, in a dose of 1.5 mequiv kg 1
day -1, caused a 44% increase in fluid intake.
Since it was of interest to evaluate the effect of lithium on renal electrolyte
transport under conditions ofknown vasopressin inhibition, studies on the renal han-
dling of sodium, potassium, and acid were performed during the intravenous in-
fusion of LiCl to achieve plasma levels of 2-5 mequiv/liter. In the present study the
action ofvasopressin was clearly impaired under this experimental condition. In ad-
dition to blocking water transport, lithium infusion resulted in a modest but
significant reduction in sodium reabsorption, a fall in the rate ofpotassium secretion
during acute potassium loading, and impaired urinary acidification. Since potassium
secretion and production of high tubular fluid concentrations of hydrogen ion are
special properties of the distal portions in the nephron, it seems likely that lithium
inhibits electrolyte secretion in the same tubular segments in which the action of
vasopressin is blocked. The tubule site(s) in which lithium reduces sodium
reabsorption cannot be determined from this study. It seems likely, however, that
sodium reabsorption was reduced in the distal portions of the nephron. Recent
studies (18) have demonstrated that the mechanism that controls the absorption of
sodium in the distal tubule and collecting duct has a powerful influence on absolute
urinary excretion, even under conditions ofincreased distal delivery.
It has recently been suggested that lithium may influence transepithelial
electrolyte movement through a partial substitution oflithium for other ions, espe-
cially sodium and potassium (10). Evidence is available showing that Na+ and Li+
share a common transport mechanism in toad urinary bladder (6) and frog skin (7).
Although Na+ and Li+ share the same pathway for cell entry, Li+ accumulates in
the cell at the expense of K+ and may increase to values 10 times the outside con-
centration (7). It is possible, therefore, that cellular accumulation of lithium may
alter the critical microenvironment of the cell required for optimal potassium and
hydrogen ion secretion and possibly for the optimal action of hormones such as
vasopressin. Medullary portions of the collecting duct would be expected to be
influenced especially by this mechanism because of the steep corticopapillary
gradient for lithium. In respect to the question of the tubular sites involved in the
reabsorption of filtered lithium, it seems apparent that direct analysis of lithium
concentrations at the level of individual nephron segments will be a necessity. The
usefulness ofclearance techniques to estimate the site(s) oflithium transport is miti-
gated by the significant direct effect of lithium on the tubular transport of other
electrolytes.
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